期刊文献+

地中海贫血患者组织因子和组织因子途径抑制物检测的临床意义 被引量:2

Clinical Significance of Detecting Tissue Factor and Tissue Factor Pathway Inhibitor in Thalassemia Patients
下载PDF
导出
摘要 目的:观察地中海贫血(地中海贫血)患者脾切除术前及术后1年外周血中E-选择素、凝血酶抗凝血酶复合物(TAT)、凝血酶原片段1+2(F1+2)、组织因子(TF)、组织因子途径抑制物(TFPI)含量的变化,探讨地中海贫血患者脾切除前后血凝状态的改变。方法:采用酶联免疫吸附法分别测定30例地中海贫血患者腹腔镜脾切除术前后血浆中E-选择素、TAT、F1+2、TF及TFPI的水平。选择30例健康体检者作为对照组。结果:地中海贫血患者脾切除术后1年患者血浆中E-选择素、TAT、 F1+2、TF、TFPI水平显著高于术前及对照组。地中海贫血患者脾切除术前血浆中E-选择素、TAT、 F1+2显著高于对照组。地中海贫血患者切脾前后血浆TF与TFPI水平均呈正相关(切脾前r=0.65,P <0.001;切脾后r=0.92,P <0.001);切脾后TF水平与TAT(r=0.75, P <0.001)及F1+2(r=0.78, P <0.001)呈正相关;切除脾后血浆TFPI水平与TAT(r=0.84, P <0.001)及F1+2(r=0.85, P <0.001)呈正相关。结论:地中海贫血患者脾切除后血小板增多、内皮细胞活化受损、促凝血因子增多,血液处于血栓前状态。TF/TFPI在地中海贫血脾切除患者血栓形成的病理过程中起重要作用,并可作为评价血液高凝状态变化的参考指标。 Objective:To investigate the changes of E-selectin,thrombin-antithrombin complex(TAT),prothrombin fragment 1+2(F1+2),tissue factor(TF)and tissue factor pathway inhibitor(TFPI)before and one year after splenectomy in thalassemia patients.Methods:A total of 30 thalassemia patients undergoing electric laparoscopic splenectomy and 30 normal controls(NC)were enrolled in the study.Plasma levels of E-selectin,TAT,F1+2,TF and TFPI were detected by enzyme-linked immuno sorbent assay(ELISA).Results:One year after splenectomy,the plasma concentrations of E-selectin,TAT,F1+2,TF,TFPI were significantly higher than those in both preoperative and NC groups.Levels of E-selectin,TAT,F1+2 before splenectomy were significantly higher than those in NC groups.In addition,there was a positive correlation between plasma TF and TFPI level before and after splenectomy,and the levels of TF and TFPI positively correlated with TAT and F1+2,respectively.Conclusion:After splenectomy,the platelet count increases,the activity of endothelial cells is injured,the procoagulant factor increases,the blood is in procoagulant state,the TF/TFPI shows an importent role in the thrombosis of thalassemia patieints after splenectomy and may be used to evaluate the prothrombotic state of this diasease.
作者 刘徽 孙娜 黄钰岚 苏谐 邓东红 程鹏 LIU Hui;SUN Na;HUANG Yu-Lan;SU Xie;DENG Dong-Hong;CHENG Peng(Department of Hematology,The First Affiliated Hospital of Guangxi Medical University,Nanning 530021,Guangxi Zhuang Autonomous Region,China)
出处 《中国实验血液学杂志》 CAS CSCD 北大核心 2018年第5期1471-1476,共6页 Journal of Experimental Hematology
基金 国家自然科学基金项目(81660025)
关键词 地中海贫血 脾切除 组织因子 组织因子途径抑制物 thalassemia splenectomy tissue factor tissue factor pathway inhibitor
  • 相关文献

同被引文献8

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部